Inventor · disambiguated record
Valeria Szijarto
Also filed as: SZIJARTO VALERIA · SZIJÁRTO VALERIA · SZIJÁRTO VALÉRIA
11 granted patents·8 pending applications·33 citations·filing 2013–2025
86Inventor score
Files withARSANIS BIOSCIENCES GMBH6JANSSEN PHARMACEUTICALS INC4X4 PHARMACEUTICALS AUSTRIA GMBH4CEBINA GmbH3EVELIQURE BIOTECHNOLOGIES GMBH2
Top patents by PatentIndex Score
19 records- 0192US10940191B2MDR E. coli specific antibodyX4 PHARMACEUTICALS AUSTRIA GMBH·Filed 2018·Granted Mar 9, 2021·9 cites·27 claims
- 0290US10206992B2MDR E. coli specific antibodyARSANIS BIOSCIENCES GMBH·Filed 2016·Granted Feb 19, 2019·9 cites·23 claims
- 0389US9849169B2MDR E. coli specific antibodyARSANIS BIOSCIENCES GMBH·Filed 2014·Granted Dec 26, 2017·13 cites·5 claims
- 0487US11433080B2Antiviral treatmentCEBINA GmbH·Filed 2021·Granted Sep 6, 2022·2 cites·23 claims
- 0582US12274742B2MDR E. coli immunogenJANSSEN PHARMACEUTICALS INC·Filed 2022·Granted Apr 15, 2025·0 cites·11 claims
- 0674US11529405B2MDR E. coli immunogenJANSSEN PHARMACEUTICALS INC·Filed 2021·Granted Dec 20, 2022·0 cites·27 claims
- 0774US2025170230A1Mdr e. coli immunogenJANSSEN PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 0864US11273163B2Antiviral treatmentCEBINA GmbH·Filed 2021·Granted Mar 15, 2022·0 cites·8 claims
- 0964US2023220055A1Antibodies targeting a galactan-based o-antigen of k. pneumoniaeX4 PHARMACEUTICALS AUSTRIA GMBH·Filed 2022·Application pending·0 cites
- 1051US12103962B2E. coli specific antibodiesJANSSEN PHARMACEUTICALS INC·Filed 2014·Granted Oct 1, 2024·0 cites·4 claims
- 1151US2020339668A1Klebsiella pneumoniae o3 specific antibodiesX4 PHARMACEUTICALS AUSTRIA GMBH·Filed 2020·Application pending·0 cites
- 1250US11466074B2Antibodies targeting a galactan-based O-antigen of K. pneumoniaeX4 PHARMACEUTICALS AUSTRIA GMBH·Filed 2015·Granted Oct 11, 2022·0 cites·14 claims
- 1350US2023225988A1Antiviral use of calixarenesCEBINA GmbH·Filed 2021·Application pending·0 cites
- 1450US2023372462A1High dose shigella vaccine preparationEVELIQURE BIOTECHNOLOGIES GMBH·Filed 2021·Application pending·0 cites
- 1548US10759848B2Klebsiella pneumoniae O3 specific antibodiesARSANIS BIOSCIENCES GMBH·Filed 2017·Granted Sep 1, 2020·0 cites·19 claims
- 1644US9730991B2Live attenuated Shigella vaccineEVELIQURE BIOTECHNOLOGIES GMBH·Filed 2013·Granted Aug 15, 2017·0 cites·29 claims
- 1740US2018298084A1Bactericidal monoclonal antibody targeting klebsiella pneumoniaeARSANIS BIOSCIENCES GMBH·Filed 2016·Application pending·0 cites
- 1836US2018312576A1Antibodies targeting a mannan-based o-antigen of k. pneumoniaeARSANIS BIOSCIENCES GMBH·Filed 2016·Application pending·0 cites
- 1935US2019161534A1Anti-galactan ii monoclonal antibodies targeting klebsiella pneumoniaeARSANIS BIOSCIENCES GMBH·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Valeria Szijarto files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →